REQUEST A DEMO
Total
USD $0.00
Search more companies

Corporacion Terapeutica Respirar (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Corporacion Terapeutica Respirar Profile Updated: March 12, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Corporacion Terapeutica Respirar is a company based in Colombia, with its head office in Bogota D.C.. The enterprise currently operates in the Ambulatory Health Care Services sector. Corporacion Terapeutica Respirar was incorporated on April 05, 2017. 2 (2026) employees currently work for Corporacion Terapeutica Respirar. In its most recent financial highlights, the company reported a net sales revenue increase of 13.23% in 2025. Its’ total assets recorded a growth of 17.64%. In 2025, Corporacion Terapeutica Respirar’s net profit margin increased by 7.69%.

Headquarters
Av Americas # 71 C 29
Bogota D.C.; Bogota D.C; Postal Code: 0616

Contact Details: Purchase the Corporacion Terapeutica Respirar report to view the information.

Basic Information
Total Employees:
Purchase the Corporacion Terapeutica Respirar report to view the information.
Financial Auditors:
Purchase the Corporacion Terapeutica Respirar report to view the information.
Incorporation Date:
April 05, 2017
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Corporacion Terapeutica Respirar report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
13.23%
Total Operating Revenue
13.23%
Net Profit/Loss for the Period
1637.39%
Total Assets
17.64%
Total Equity
92.71%
Net Profit Margin
7.69%
Return on Equity (ROE)
37.65%
Quick Ratio
2861.47%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?